FDA企业注册 - 相关文章

美国FDA、OTC、NDC化妆品申报认证行业资讯,助力企业合规出海

去屑洗发水美国OTC合规:ZPT在美仍合法,与欧盟禁用监管差异解析

2026年中国去屑洗护出口美国需遵循FDA OTC专论M032,煤焦油、二硫化硒、水杨酸、硫磺及吡硫翁锌(ZPT)均为合规活性成分。与欧盟2022年禁用ZPT不同,美国仍将ZPT列为合法OTC去屑成分。企业须按专论浓度与Drug Facts标签要求申报,并办理NDC注册。

防晒OTC专论GRASE活性成分解读与2026 Bemotrizinol新规

2026年FDA将Bemotrizinol纳入OTC防晒专论,叠加CARES Act行政命令框架,防晒剂合规迎来新变化。目前仅氧化锌与二氧化钛被认定为GRASE安全成分,其余化学防晒剂因数据不足需重新评估。出口企业须按21 CFR 352专论调整配方与标签,避免上市后被扣留。

21 CFR Part 331 -- Antacid Products for Over-the-Counter (OTC) Human Use

21 CFR Part 331 -- Antacid Products for Over-the-Counter (OTC) Human UsePART 331—ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:39 FR 19874, June 4, 1974, unless otherwise noted.Subpa

21 CFR Part 333 Subpart B - First Aid Antibiotic Drug Products

21 CFR Part 333 Subpart B - First Aid Antibiotic Drug ProductsSubpart B—First Aid Antibiotic Drug Products§ 333.101 Scope.(a) An over-the-counter first aid antibiotic drug product in a form suitable for topical administration is generally recognized

21 CFR Part 332 - Antiflatulent Products for Over-the-Counter Human Use

21 CFR Part 332 - Antiflatulent Products for Over-the-Counter Human UsePART 332—ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:39 FR 19877, June 4, 1974, unless otherwise noted.Subpar

21 CFR Part 333 Subpart C—Topical Antifungal Drug Products

21 CFR Part 333 Subpart C—Topical Antifungal Drug ProductsSubpart C—Topical Antifungal Drug ProductsSource:58 FR 49898, Sept. 23, 1993, unless otherwise noted.§ 333.201 Scope.(a) An over-the-counter antifungal drug product in a form suitable for topi

21 CFR Part 333 Subpart D—Topical Acne Drug Products

21 CFR Part 333 Subpart D—Topical Acne Drug ProductsSubpart D—Topical Acne Drug ProductsSource:56 FR 41019, Aug. 16, 1991, unless otherwise noted.§ 333.301 Scope.(a) An over-the-counter acne drug product in a form suitable for topical application is